Impact of Vendor Systems on Ambulatory Medication Safety (BWHCERT5E)

Weill Cornell Medicine (WCM)

Status: Completed

Conditions: Medication Errors

Treatments: Other: Electronic prescribing

Study type: Observational

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT00773500

U18HS0169705E

Details and patient eligibility

About

Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.

Full description

We will compare the effects of different vendor-based electronic prescribing systems on ambulatory medication safety in various settings, including rural and underserved areas and determine the effects of electronic prescribing systems on ambulatory medication safety over time.

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• >=0.75 FTE providers

Exclusion criteria

• <0.75 FTE providers

Trial design

20 participants in 2 patient groups

1

Description:

Providers adopting electronic prescribing in New York City, New York

Treatment:

Other: Electronic prescribing

2

Description:

Providers adopting electronic prescribing in the Taconic region of New York

Treatment:

Other: Electronic prescribing